Genomic classifier appears to predict metastasis in prostate cancer patients following prostatectomy
For men with prostate cancer who have had a prostatectomy and salvage radiation therapy (SRT), analyzing their tumor genome provides clues as to whether their cancer will metastasize, therefore enabling clinicians to better personalize treatment options, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 57th Annual Meeting. Prostate cancer treatment varies based on the severity and stage of the disease, with some patients requiring prostatectomy, which is the surgical removal of the prostate. For those patients who develop elevated prostate-